[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BalaBioResearch BalaBio Research BalaBio Research posts on X about $crnx, $bmrn, $eypt, $ocul the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1930394110906580992/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +28% ### Mentions: X [#](/creator/twitter::1930394110906580992/posts_active)  - X Week XX -XX% - X Month XX -XXXX% ### Followers: XXXXX [#](/creator/twitter::1930394110906580992/followers)  - X Week XXXXX +1.20% - X Month XXXXX +19% ### CreatorRank: undefined [#](/creator/twitter::1930394110906580992/influencer_rank)  ### Social Influence [#](/creator/twitter::1930394110906580992/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [technology brands](/list/technology-brands) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$crnx](/topic/$crnx) #6, [$bmrn](/topic/$bmrn) #18, [$eypt](/topic/$eypt) #2, [$ocul](/topic/$ocul) 1.79%, [$slno](/topic/$slno) 1.79%, [$cort](/topic/$cort) 0.89%, [$fold](/topic/$fold) 0.89%, [positions](/topic/positions) 0.89%, [$abeo](/topic/$abeo) 0.89%, [$rare](/topic/$rare) XXXX% **Top accounts mentioned or mentioned by** [@lcccc333](/creator/undefined) [@biotech2k1](/creator/undefined) [@melvinriskmgmt](/creator/undefined) [@jeremyj0916](/creator/undefined) [@yachmod](/creator/undefined) [@aditharun](/creator/undefined) [@physioo](/creator/undefined) [@jeremyfalmouth](/creator/undefined) [@clarkjon88](/creator/undefined) [@phoenix3million](/creator/undefined) [@mickeychiku](/creator/undefined) [@respekchemistry](/creator/undefined) [@biotechsanya2](/creator/undefined) [@financebully](/creator/undefined) [@nasdaqexchange](/creator/undefined) [@alexahdoot](/creator/undefined) [@sanctuarybio](/creator/undefined) [@dedwng](/creator/undefined) [@pikacapital](/creator/undefined) [@usfda](/creator/undefined) **Top assets mentioned** [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [SuperRare (RARE)](/topic/$rare) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Arvinas, Inc (ARVN)](/topic/$arvn) ### Top Social Posts [#](/creator/twitter::1930394110906580992/posts) --- Top posts by engagements in the last XX hours "Highest conviction long positions going into 2H25: (In order) $CORT* Corcept Therapeutics $ABEO* Abeona $RARE / $MREO* Ultragenyx/Mereo $SRPT Sarepta $CRNX Crinetics $FOLD* Amicus $BMRN BioMarin *research report posted" [X Link](https://x.com/BalaBioResearch/status/1940500962088755458) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-07-02T20:00Z 1030 followers, 1382 engagements "$CRNX goat management team" [X Link](https://x.com/BalaBioResearch/status/1973059868442374321) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-30T16:18Z 1031 followers, 4248 engagements "$CRNX probably should've 2x+ in market cap based on the pricing news on approval day. Why wouldn't paltu hit 5b peak revenue 🤷♂" [X Link](https://x.com/BalaBioResearch/status/1975965746128970230) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-08T16:45Z 1030 followers, 2694 engagements "$EYPT 172.5m raise and initiating DME pivotal. I don't see $EYPT and $OCUL as a winner take all competition the market is massive. There could be big profit in playing equal position in both" [X Link](https://x.com/BalaBioResearch/status/1978215637068435753) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-14T21:45Z 1031 followers, 2125 engagements "Half these assets are worthless but $RZLT makes a lot of sense for $BMRN" [X Link](https://x.com/BalaBioResearch/status/1968414894299959500) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-17T20:40Z 1031 followers, 3261 engagements "Time to load up on $EYPT" [X Link](https://x.com/BalaBioResearch/status/1978491209715691995) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-15T16:00Z 1031 followers, 1200 engagements "$AARD $SLNO $RYTM This a a great visualization of the MC4R pathway from RYTMs new presentation. Remember that in PWS the POMC neurons are underactive and the AgRP neurons are overactive each causing there to be less MC4R activation" [X Link](https://x.com/BalaBioResearch/status/1965519156281004356) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-09T20:54Z 1030 followers, 2758 engagements "The $ARVN phase X data was so good that the CEO left when his other asset failed" [X Link](https://x.com/BalaBioResearch/status/1974908154568982613) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-05T18:42Z 1031 followers, 3530 engagements "$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved" [X Link](https://x.com/BalaBioResearch/status/1977214065178264007) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-12T03:25Z 1030 followers, 2116 engagements "$SLNO Seeing some analyst coverage on this and I think its really important Vykat has weight based dosing and does NOT have a flat price per patient revenue could massively surprise to the upside off titration from launch q patients" [X Link](https://x.com/BalaBioResearch/status/1978529272055672956) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-15T18:31Z 1031 followers, 4001 engagements "@MelvinRiskMgmt @plainyogurt21 Look at their operations they barely have any overhead at all. No r&d and a tiny salesforce. The patients seek the drug" [X Link](https://x.com/BalaBioResearch/status/1978609596303396944) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-15T23:51Z 1031 followers, XXX engagements "@Respekchemistry Maybe distrust of the genetx pipeline 🤷♂ vyj has always been a great drug that would sell amazingly well" [X Link](https://x.com/BalaBioResearch/status/1979206694849720651) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-17T15:23Z 1031 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BalaBioResearch BalaBio Research
BalaBio Research posts on X about $crnx, $bmrn, $eypt, $ocul the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX +28%
Mentions: X #
- X Week XX -XX%
- X Month XX -XXXX%
Followers: XXXXX #
- X Week XXXXX +1.20%
- X Month XXXXX +19%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXX% cryptocurrencies XXXX% technology brands XXXX% finance XXXX%
Social topic influence $crnx #6, $bmrn #18, $eypt #2, $ocul 1.79%, $slno 1.79%, $cort 0.89%, $fold 0.89%, positions 0.89%, $abeo 0.89%, $rare XXXX%
Top accounts mentioned or mentioned by @lcccc333 @biotech2k1 @melvinriskmgmt @jeremyj0916 @yachmod @aditharun @physioo @jeremyfalmouth @clarkjon88 @phoenix3million @mickeychiku @respekchemistry @biotechsanya2 @financebully @nasdaqexchange @alexahdoot @sanctuarybio @dedwng @pikacapital @usfda
Top assets mentioned Crinetics Pharmaceuticals, Inc. (CRNX) BioMarin Pharmaceutical, Inc. (BMRN) Soleno Therapeutics, Inc. Common Stock (SLNO) Corcept Therapeutics Inc. (CORT) Amicus Therapeutics, Inc (FOLD) SuperRare (RARE) Sarepta Therapeutics, Inc. (SRPT) Praxis Precision Medicines, Inc. Common Stock (PRAX) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Arvinas, Inc (ARVN)
Top Social Posts #
Top posts by engagements in the last XX hours
"Highest conviction long positions going into 2H25: (In order) $CORT* Corcept Therapeutics $ABEO* Abeona $RARE / $MREO* Ultragenyx/Mereo $SRPT Sarepta $CRNX Crinetics $FOLD* Amicus $BMRN BioMarin *research report posted"
X Link @BalaBioResearch 2025-07-02T20:00Z 1030 followers, 1382 engagements
"$CRNX goat management team"
X Link @BalaBioResearch 2025-09-30T16:18Z 1031 followers, 4248 engagements
"$CRNX probably should've 2x+ in market cap based on the pricing news on approval day. Why wouldn't paltu hit 5b peak revenue 🤷♂"
X Link @BalaBioResearch 2025-10-08T16:45Z 1030 followers, 2694 engagements
"$EYPT 172.5m raise and initiating DME pivotal. I don't see $EYPT and $OCUL as a winner take all competition the market is massive. There could be big profit in playing equal position in both"
X Link @BalaBioResearch 2025-10-14T21:45Z 1031 followers, 2125 engagements
"Half these assets are worthless but $RZLT makes a lot of sense for $BMRN"
X Link @BalaBioResearch 2025-09-17T20:40Z 1031 followers, 3261 engagements
"Time to load up on $EYPT"
X Link @BalaBioResearch 2025-10-15T16:00Z 1031 followers, 1200 engagements
"$AARD $SLNO $RYTM This a a great visualization of the MC4R pathway from RYTMs new presentation. Remember that in PWS the POMC neurons are underactive and the AgRP neurons are overactive each causing there to be less MC4R activation"
X Link @BalaBioResearch 2025-09-09T20:54Z 1030 followers, 2758 engagements
"The $ARVN phase X data was so good that the CEO left when his other asset failed"
X Link @BalaBioResearch 2025-10-05T18:42Z 1031 followers, 3530 engagements
"$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved"
X Link @BalaBioResearch 2025-10-12T03:25Z 1030 followers, 2116 engagements
"$SLNO Seeing some analyst coverage on this and I think its really important Vykat has weight based dosing and does NOT have a flat price per patient revenue could massively surprise to the upside off titration from launch q patients"
X Link @BalaBioResearch 2025-10-15T18:31Z 1031 followers, 4001 engagements
"@MelvinRiskMgmt @plainyogurt21 Look at their operations they barely have any overhead at all. No r&d and a tiny salesforce. The patients seek the drug"
X Link @BalaBioResearch 2025-10-15T23:51Z 1031 followers, XXX engagements
"@Respekchemistry Maybe distrust of the genetx pipeline 🤷♂ vyj has always been a great drug that would sell amazingly well"
X Link @BalaBioResearch 2025-10-17T15:23Z 1031 followers, XXX engagements